Drug Treatment for Alcoholics With Bipolar Disorder

Completed · Phase 2 · Has a placebo group

Conditions studied: Alcoholism, Bipolar Disorder

In brief

The purpose of this study is to test the effectiveness of sodium valproate (Depacon) in treating individuals with alcohol dependence and comorbid bipolar disorder.

Key facts

Study ID
NCT00000439
Run by
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
People needed
72
Starts
2000-10-01
Expected to finish
2003-08-01
Last updated by the study team
2018-01-18

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.